Three Biotech Investment Ideas from Cormorant Asset Management
The biotech industry is regaining ground it lost in 2016 at full speed. The sector was very hot until around mid-2015, with the iShares Nasdaq Biotechnology......(read more)
Posts Tagged ‘Bihua Chen’
Sunesis Pharmaceuticals Inc (SNSS): Cormorant Asset Management Reports New 5.14% Stake
Sunesis Pharmaceuticals Inc (NASDAQ:SNSS) has a new shareholder in the form of Bihua Chen‘s Cormorant Asset Management. As per a new 13G filing......(read more)
Myokardia Inc (MYOK): Cormorant Asset Management Raises Its Stake
A recent 13G filing with the Securities and Exchange Commission revealed that Bihua Chen‘s Cormorant Asset Management has boosted its stake in ......(read more)
Cormorant Asset Management Doesn’t Think Corbus Pharmaceuticals Holdings Inc. (CRBP) Is Done Soaring Just Yet
In a new 13G filing with the SEC, Bihua Chen‘s Cormorant Asset Management reported owning 2.35 million shares of Corbus Pharmaceuticals Holdings......(read more)
Gemphire Therapeutics Inc. (GEMP): Cormorant Asset Management Reports New Stake
According to a new 13G filing with the Securities and Exchange Commission, Bihua Chen‘s Cormorant Asset Management owns 900,000 shares of Gemphire......(read more)
Clearside Biomedical Inc (CLSD): Cormorant Reveals 10.1% Stake
Bihua Chen‘s Cormorant Asset Management has revealed a position in Clearside Biomedical Inc (NASDAQ:CLSD), through a 13G filing issued with the......(read more)
Quotient Ltd (QTNT): Bihua Chen’s New Fund, Cormorant Asset Management, Triples Stake
Bihua Chen’s Cormorant Asset Management disclosed, last Thursday, that it had tripled its exposure to Quotient Ltd (NASDAQ:QTNT), from 500,000 shares......(read more)
